
VERU
USDVeru Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$2.580
Máximo
$2.650
Mínimo
$2.580
Volumen
0.18M
Fundamentos de la Empresa
Capitalización de Mercado
42.5M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.18M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Informe de Análisis de IA
Última actualización: 10 nov 2025VERU Stock Analysis: Veru Inc. Navigates Volatility Amid Fundamental Challenges
Market Snapshot
Current Price: $2.61 (as of 2025-11-10) 52-Week Range: $2.42 - $14.20 Market Cap: $41.89M | P/E Ratio: -9.00 Recent Volatility: Sharp decline from $4.43 (Oct 20) to $2.61, with erratic volume patterns
Recent Performance: Turbulent Descent
Veru’s stock has been in a clear downtrend since mid-October, shedding 41% from its October peak. Key observations:
- Public Offering Impact: The $25M offering on Oct 30 likely triggered selling pressure, with shares dropping 12% the following day.
- Volume Anomalies: Unusually high trading volume on Oct 30 ($765,700) and Nov 3 ($489,500) suggests panic selling or institutional exits.
- Support Zone: Recent closes near $2.52-$2.58 align with its 52-week low, indicating this range may act as temporary support.
Technical Signals: Mixed Messages
- Bullish DMI: +DI (15.4) > -DI (14.1) with ADX at 19.0 implies a weak uptrend could form if buyers step in.
- Volume Surge: 1.9x average volume on Nov 10 hints at renewed interest, but this could reflect short-term positioning rather than sustainable demand.
- MACD Death Cross: Bearish momentum confirmed as MACD (0.0119) fell below signal line (0.0162) despite AI’s upward projections.
Fundamentals: Value Trap or Hidden Potential?
- Contradictory Valuation: While the P/E (-9.00) appears broken due to negative earnings, the recommendation claims it’s “0.4x industry average” (likely referencing EBITDA multiples or forward estimates). Proceed with skepticism.
- **High-Risk
Noticias Relacionadas
Veru to Present Two Abstracts at ObesityWeek 2025
MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory
Veru Announces Pricing of $25 Million Public Offering
MIAMI, FL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory
Predicción de IABeta
Recomendación de IA
Actualizado el: 10 nov 2025, 14:42
58.4% Confianza
Riesgo y Negociación
Punto de Entrada
$2.52
Toma de Ganancias
$2.61
Stop Loss
$2.30
Factores Clave
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.